EP Mobile vs TRI

EP Mobile provides tools for cardiac electrophysiologists, cardiologists, cardiology fellows, internists, emergency room physicians, medical students, nurses, technicians, and other health care workers who deal with cardiac arrhythmias. If you have suggestions, features you'd like to see, or complaints, please email us! EP Mobile -- The Swiss Army Knife of Electrophysiology! Features: - All modules fully referenced with links to articles - Copy results to clipboard to paste into other apps - Below is a limited list of modules, more modules are added frequently - Pacing maneuvers: para-Hisian pacing and RV apex vs base pacing - Heart rhythm drugs and anticoagulants reference: dabigatran, dofetilide, rivaroxaban, sotalol, apixaban, edoxaban - Creatinine clearance calculator - Warfarin clinic utility - Interval to rate conversion - QTc calculator (Bazett, Fridericia, Sagie and Hodges formulas) - Additional QTc calculators for IVCD - QT prolongation risk score - Date calculator - Atrial fibrillation risk scores (CHADS2, CHA2DS2-VASc, ATRIA scores) - Bleeding risk scores (HAS-BLED, HEMORR2HAGES, SAMe-TT2R2, ORBIT) - Hypertrophic Cardiomyopathy SCD risk scores (2002, 2014, 2022, 2024) - ICD implantation risk score - ICD mortality risk score - Syncope risk scores (EGSYS, Martin, OESIL, SF) - CMS (Medicare) ICD guidelines calculator, now updated to new 2018 criteria - Atrial tachycardia location algorithm - VT localization algorithms - Epicardial vs endocardial VT - Outflow tract VT - Mitral annular VT - Entrainment mapping - WPW accessory pathway location (Arruda, Modified Arruda, D'Avila, Milstein and others) - Long QT diagnosis, subtypes, and ECG patterns - Short QT syndrome diagnosis - Brugada syndrome diagnosis - Early Repolarization syndrome diagnosis - LVH ECG criteria, including Romhilt-Estes score and others - RVH ECG criteria - True LBBB criteria - ARVC/D 1994 and 2010 diagnostic criteria - ARVC/D risk calculator - Normal EP values - Wide complex tachycardia diagnosis

It is a simple, accurate and dedicated risk-score model to predict outcome after isolated tricuspid valve surgery for severe tricuspid regurgitation at an individual level according to the pre-operative clinical, biological and echocardiographic presentation. It has been developed from 466 consecutive adult patients who underwent an isolated tricuspid valve surgery on native valve for non- congenital severe tricuspid regurgitation at 12 tertiary French centers between January 1, 2007 and December 31, 2017. Its aim is to guide the clinical decision-making process in routine practice.